MREO — Mereo BioPharma Cashflow Statement
0.000.00%
Last trade - 00:00- $504.88m
- $454.36m
- £7.91m
Annual cashflow statement for Mereo BioPharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | 20-F | 20-F | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -41.1 | -166 | 14.2 | -36.1 | -34.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.207 | 129 | -21.1 | -3.75 | 15.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.6 | 7.02 | 0.98 | 0.292 | 0.607 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -45.9 | -28.3 | -5.24 | -38.8 | -17.6 |
| Capital Expenditures | -0.021 | -0.016 | -0.535 | -0.01 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 43.3 | 1.51 | 0.114 | 1.51 | 1.29 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 43.3 | 1.5 | -0.421 | 1.5 | 1.29 |
| Financing Cash Flow Items | -2.5 | -7.89 | -0.234 | 0.153 | -1.07 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.71 | 34.7 | 77.7 | -0.784 | 5.09 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.7 | 7.12 | 70.8 | -38 | -11.2 |